Gut bacteria byproducts may control appetite and blood sugar
NCT ID NCT06686888
First seen Feb 27, 2026 · Last updated Jun 20, 2026 · Updated 14 times
Summary
This study tested whether short-chain fatty acids (SCFAs) released in the small intestine or colon affect hunger-related hormones. Twenty-eight healthy adults took capsules containing SCFAs or a placebo, and their blood was sampled over eight hours. The goal was to see if where SCFAs are delivered changes hormone release, which could inform future appetite and metabolism treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOSE HOMEOSTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
KU Leuven
Leuven, 3000, Belgium
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
short-chain fatty acids (SCFA) as dietary supplements
What this could lead to
If successful, this could help design better dietary strategies to control appetite and blood sugar.
What could go wrong
This is a small, early-stage study in healthy people, so results may not apply to those with medical conditions. It only measures short-term effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.